ALX ONCOLOGY HOLDINGS INC (ALXO) Free cash flow 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$84.4MFY2025 · since FY2018: -$13.8M → -$84.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.4M | +31.1% |
| FY2024 | -$122.4M | +7.0% |
| FY2023 | -$131.6M | -45.2% |
| FY2022 | -$90.7M | -31.8% |
| FY2021 | -$68.8M | -79.5% |
| FY2020 | -$38.3M | -162.4% |
| FY2019 | -$14.6M | -5.5% |
| FY2018 | -$13.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net incomeALXO Net marginALXO Gross profitALXO Gross marginALXO Operating incomeALXO Operating marginALXO Operating cash flowALXO Capital expendituresALXO Return on equityALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Total liabilitiesALXO Shareholders’ equityALXO overview →